Logothetis, C.N.; Patel, A.; Eatrides, J.; Jaglal, M.; Haider, M.; Visweshwar, N.; Laber, D.A.
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution. J. Clin. Med. 2021, 10, 3418.
https://doi.org/10.3390/jcm10153418
AMA Style
Logothetis CN, Patel A, Eatrides J, Jaglal M, Haider M, Visweshwar N, Laber DA.
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution. Journal of Clinical Medicine. 2021; 10(15):3418.
https://doi.org/10.3390/jcm10153418
Chicago/Turabian Style
Logothetis, Constantine N., Ankita Patel, Jennifer Eatrides, Michael Jaglal, Mintallah Haider, Nathan Visweshwar, and Damian A. Laber.
2021. "Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution" Journal of Clinical Medicine 10, no. 15: 3418.
https://doi.org/10.3390/jcm10153418
APA Style
Logothetis, C. N., Patel, A., Eatrides, J., Jaglal, M., Haider, M., Visweshwar, N., & Laber, D. A.
(2021). Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution. Journal of Clinical Medicine, 10(15), 3418.
https://doi.org/10.3390/jcm10153418